aTTP New Guidelines: Podcast
Acquired Thrombotic Thrombocytopenic Purpura: Clinical Application of Precision Medicine and New Guidelines

Released: February 01, 2022

Expiration: January 31, 2023

Paul Coppo
Paul Coppo, MD, PhD
Ara Metjian
Ara Metjian, MD

Activity

Progress
1
Course Completed

In this episode, Ara Metjian, MD; Paul Coppo, MD, PhD; and Marshal Mazepa, MD, answer questions from an audience of healthcare professionals on topics related to the management of acquired thrombotic thrombocytopenic purpura (aTTP), including:  

  • Rationale of the CAPLAVIE regimen of caplacizumab with corticosteroids and rituximab in aTTP in the acute phase
  • Data for caplacizumab in pediatric patients with aTTP
  • Initiating rituximab after completion of plasma exchange
  • International Society on Thrombosis and Haemostasis guideline recommendations against using aspirin
  • Triggers of aTTP episodes aside from infection
  • Effect of COVID-19 vaccines and COVID-19 infections on aTTP onset or relapse